Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology and Hepatology
Volume 28 (2014), Issue 1, Pages 41-44
http://dx.doi.org/10.1155/2014/839014
Original Article

One Year of Hepatitis B Immunoglobulin Plus Tenofovir Therapy is Safe and Effective in Preventing Recurrent Hepatitis B Infection Post-Liver Transplantation

Tomohiro Tanaka,1,2 Eberhard L Renner,1 Nazia Selzner,1 George Therapondos,1 and Leslie B Lilly1

1Multi-Organ Transplant Program, Liver Transplant Unit, University Health Network, University of Toronto, Toronto, Ontario, Canada
2Organ Transplantation Service, The University of Tokyo Hospital, Tokyo, Japan

Received 6 July 2013; Accepted 11 August 2013

Copyright © 2014 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Tomohiro Tanaka, Eberhard L Renner, Nazia Selzner, George Therapondos, and Leslie B Lilly, “One Year of Hepatitis B Immunoglobulin Plus Tenofovir Therapy is Safe and Effective in Preventing Recurrent Hepatitis B Infection Post-Liver Transplantation,” Canadian Journal of Gastroenterology and Hepatology, vol. 28, no. 1, pp. 41-44, 2014. doi:10.1155/2014/839014